The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China.
Ann Med. 2023;55(2):2251500. doi: 10.1080/07853890.2023.2251500.
Endoplasmic reticulum stress (ERs) is an important cellular self-defence mechanism, which is closely related to tumorigenesis and development. However, the role of endoplasmic reticulum stress state in the development of lung adenocarcinoma (LUAD) has not been clarified.
The lncRNAs associated with endoplasmic reticulum stress were identified by co-expression analysis in public databases, and by the least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression modelling, we constructed a prognostic model based on endoplasmic reticulum stress-related lncRNAs (ERs-related lncRNAs), performed immune analysis, TME, TMB and clinical drug prediction for model-related risk scores, and performed correlation validation in public databases and at the human tissue level.
Five ERs-related lncRNAs were used to construct an ERs-related lncRNA signature (ERs-related LncSig), which can predict the prognosis of LUAD. Patients in the high-risk group had worse survival, and differences existed in immune cell infiltration, immune function, immune checkpoint analysis, tumour microenvironment (TME), tumour mutational burden (TMB), immunotherapy efficacy, and sensitivity to some commonly used chemotherapeutic agents between high and low risk groups.
Our study demonstrated that ERs-related lncRNA signature can be used for the prognostic evaluation of LUAD patients and may provide new insights into clinical decision-making and personalised medicine for LUAD.
内质网应激(ERs)是一种重要的细胞自我防御机制,与肿瘤的发生和发展密切相关。然而,内质网应激状态在肺腺癌(LUAD)发展中的作用尚未阐明。
通过公共数据库中的共表达分析,以及最小绝对收缩和选择算子(LASSO)回归和多变量 Cox 回归模型,确定与内质网应激相关的 lncRNAs,并基于内质网应激相关 lncRNAs(ERs-related lncRNAs)构建预后模型,进行免疫分析、TME、TMB 和临床药物预测模型相关风险评分,并在公共数据库和人类组织水平进行相关性验证。
使用 5 个 ERs-related lncRNAs 构建了一个 ERs-related lncRNA 特征(ERs-related LncSig),可以预测 LUAD 的预后。高危组患者的生存状况较差,在免疫细胞浸润、免疫功能、免疫检查点分析、肿瘤微环境(TME)、肿瘤突变负荷(TMB)、免疫治疗效果以及对一些常用化疗药物的敏感性方面,高低风险组之间存在差异。
本研究表明,ERs-related lncRNA 特征可用于 LUAD 患者的预后评估,并可能为 LUAD 的临床决策和个体化医学提供新的见解。